Main Article Content
Dr. Jen Gommerman received her the University Ph.D. (Immunology) of Toronto in at 1998. She went on to do a post-doctoral fellowship at Harvard Medical School studying the complement pathway and then joined Biogen Inc. as a Staﬀ Scientist in 2000. During her tenure at Biogen, she became interested in B cells, multiple sclerosis, and the TNF superfamily of molecules. After 3 years in Industry, she returned to Academia as an Assistant Professor (Immunology) at the University of Toronto in 2003, and in 2015 was promoted to full Professor. Dr. Gommerman's basic research continues to focus on how members of the TNF superfamily of molecules regulate immunity and autoimmunity. Her team has uncovered a novel gut-brain axis that regulates neuroinﬂammation. With respect to translational work, Dr. Gommerman has been examining the role of B lymphocytes in multiple sclerosis patients, and she is the lead investigator on a study examining the eﬀect of global migration on susceptibility to autoimmune disease.